ArticleJCO oncology practice2021

Trend in Tyrosine Kinase Inhibitor Utilization, Price, and Out-of-Pocket Costs in Patients With Chronic Myelogenous Leukemia.

Brian Talon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.